These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8518220)

  • 21. Phase II study of carboplatin in patients with advanced or recurrent endometrial carcinoma. A trial of the EORTC Gynaecological Cancer Group.
    van Wijk FH; Lhommé C; Bolis G; Scotto di Palumbo V; Tumolo S; Nooij M; de Oliveira CF; Vermorken JB;
    Eur J Cancer; 2003 Jan; 39(1):78-85. PubMed ID: 12504662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I clinical trial of doxorubicin and iproplatin combination chemotherapy in patients with breast cancer.
    Casper ES; Curley T; Hakes TB
    Invest New Drugs; 1989 Jul; 7(2-3):189-93. PubMed ID: 2793371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I/II study of intraperitoneal iproplatin in patients with minimal residual disease following platinum-based systemic therapy for epithelial ovarian carcinoma.
    Murphy D; Lind MJ; Prendiville J; Renninson J; Smith DR; Thompson G; Ranson M; Crowther D
    Eur J Cancer; 1992; 28A(4-5):870-2. PubMed ID: 1524912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of carboplatin in patients with advanced melanoma.
    Casper ES; Bajorin D
    Invest New Drugs; 1990 May; 8(2):187-90. PubMed ID: 1696568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.
    Hubbard KP; Pazdur R; Ajani JA; Braud E; Blaustein A; King M; Llenado-Lee M; Winn R; Levin B; Abbruzzese JL
    Am J Clin Oncol; 1992 Dec; 15(6):524-7. PubMed ID: 1449117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of carboplatin or iproplatin in cervical cancer.
    Lira-Puerto V; Silva A; Morris M; Martinez R; Groshen S; Morales-Canfield F; Tenorio F; Muggia F
    Cancer Chemother Pharmacol; 1991; 28(5):391-6. PubMed ID: 1914084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days.
    Sessa C; Minoia C; Ronchi A; Zucchetti M; Bauer J; Borner M; de Jong J; Pagani O; Renard J; Weil C; D'Incalci M
    Ann Oncol; 1998 Dec; 9(12):1315-22. PubMed ID: 9932162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of iproplatin (CHIP, JM-9) in advanced testicular cancers progressing after prior chemotherapy.
    Clavel M; Monfardini S; Gundersen S; Kaye S; Siegenthaler P; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1345-8. PubMed ID: 3181255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
    Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
    Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of iproplatin (CHIP, JM-9) in advanced squamous cell carcinoma of the head and neck.
    Abele R; Clavel M; Monfardini S; Bruntsch U; Renard J; van Glabbeke M; Pinedo HM
    Eur J Cancer Clin Oncol; 1987 Apr; 23(4):387-9. PubMed ID: 3609103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized phase II evaluation of iproplatin (CHIP) and carboplatin (CBDCA) in lung cancer. A Southeastern Cancer Study Group trial.
    Kramer BS; Birch R; Greco A; Prestridge K; DeSimone P; Omura G
    Am J Clin Oncol; 1988 Dec; 11(6):643-5. PubMed ID: 2847524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer.
    Fountzilas G; Athanassiades A; Papadimitriou V; Dimopoulos MA; Bafaloukos D; Aravantinos G; Nicolaides C; Kalofonos H; Papakostas P; Xiros N; Razi E
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 1):45-8. PubMed ID: 9516604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antitumor effect of carboplatin and iproplatin on human urinary bladder and prostatic cancers grown in nude mice].
    Hasegawa J; Kawamura N; Yamada S; Tsuboi N; Akimoto M
    Gan To Kagaku Ryoho; 1987 Dec; 14(12):3279-83. PubMed ID: 3318705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
    Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
    Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
    [No Abstract]   [Full Text] [Related]  

  • 35. Lung tumour growth delay and normal tissue toxicity induced by three cytotoxic platinum drugs.
    van Rongen E; Kal HB; Kuijpers WC; van Berkel AH
    Strahlenther Onkol; 1992 May; 168(5):300-7. PubMed ID: 1598667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative effect of cisplatin, spiroplatin, carboplatin and iproplatin in a human tumor clonogenic assay.
    Schroyens W; Dodion P; Rozencweig M
    J Cancer Res Clin Oncol; 1990; 116(4):392-6. PubMed ID: 2202731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical development of iproplatin (CHIP).
    Creaven PJ; Pendyala L; Madajewicz S
    Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of iproplatin in advanced or metastatic stomach cancer. The EORTC Early Clinical Trial Group.
    Sessa C; Cerny T; Kaye S; Monfardini S; Rénard J; Cavalli F
    Eur J Cancer; 1990 Jan; 26(1):61-2. PubMed ID: 2138481
    [No Abstract]   [Full Text] [Related]  

  • 39. Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial.
    von Minckwitz G; Schneeweiss A; Loibl S; Salat C; Denkert C; Rezai M; Blohmer JU; Jackisch C; Paepke S; Gerber B; Zahm DM; Kümmel S; Eidtmann H; Klare P; Huober J; Costa S; Tesch H; Hanusch C; Hilfrich J; Khandan F; Fasching PA; Sinn BV; Engels K; Mehta K; Nekljudova V; Untch M
    Lancet Oncol; 2014 Jun; 15(7):747-56. PubMed ID: 24794243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carboplatin or iproplatin in advanced non-small cell lung cancer: a Cancer and Leukemia Group B Study.
    Kreisman H; Ginsberg S; Propert KJ; Richards F; Graziano S; Green M
    Cancer Treat Rep; 1987 Nov; 71(11):1049-52. PubMed ID: 2824045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.